✦ LIBER ✦

Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer

✍ Scribed by Komiya, T; Coxon, A; Park, Y; Chen, W-D; Zajac-Kaye, M; Meltzer, P; Karpova, T; Kaye, F J

Book ID: 109971227
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 649 KB
Volume: 29
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2009.453

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of activator protein-1 activi

Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer

✍ Katsuyuki Ichiki; Noriyasu Mitani; Yoshinori Doki; Hiroiku Hara; Takuro Misaki; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 161 KB

Enhancement of antitumor activity of cis

Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1

✍ Deng, W-G; Wu, G; Ueda, K; Xu, K; Roth, J A; Ji, L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Co-expression of LKB1, MO25α and STRADα

Co-expression of LKB1, MO25α and STRADα in bacteria yield the functional and active heterotrimeric complex

✍ Dietbert Neumann; Marianne Suter; Roland Tuerk; Uwe Riek; Theo Wallimann 📂 Article 📅 2007 🏛 Humana Press Inc 🌐 English ⚖ 413 KB

The role and regulation of the nuclear r

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer

✍ Tyler Lahusen; Ralf T. Henke; Benjamin L. Kagan; Anton Wellstein; Anna T. Riegel 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 406 KB

Monocarboxylate transporters 1 and 4 are

Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells

✍ Hiroto Izumi; Mayu Takahashi; Hidetaka Uramoto; Yoshifumi Nakayama; Tsunehiro Oy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Enhanced EGR1 activity promotes the grow

Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment

✍ Shan-Zhong Yang; Isam A. Eltoum; Sarki A. Abdulkadir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 1 views

## Abstract During anti‐hormonal therapy for prostate cancer, a major clinical problem is the development of androgen‐independent disease. The molecular mechanisms underlying the transition to androgen independence are the subject of intense investigation. In many prostate tumors, the activity of t